Evaluation of Anti-tumor Immunity in Cancer Patients through Peripheral Blood Natural Killer Cell Measurements: A Review |
Jang, Sung-Il
(East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University)
Choi, Jung-Eun (East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) Lee, Yeon-Weol (East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) Cho, Chong-Kwan (East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Oriental Hospital of Daejeon University) |
1 | 홍원식 편저. 精校黃帝內經素問. 서울, 동양의학연구원출판사, p37-38, 55, 57, 78, 82, 118-119, 122, 181, 213, 249, 256, 304, 305, 319, 326, 347-348, 1981. |
2 | 조종관. 한방임상종양학. 대전, 주민출판사, p140, 2001. |
3 | Yoon, J., Yoo, H.S., Lee, Y.W., Cho, C.K. An overview of current oriental medicine herbal cancer research in Korea. Chin J Integr Med. 17(4):251-256, 2011. DOI |
4 | Park, H.M., Kim, S.Y., Jung, I.C., Lee, Y.W., Cho, C.K., Yoo, H.S. Integrative tumor board: a case report and discussion from East-West Cancer Center. Integr Cancer Ther. 9(2):236-245, 2010. |
5 | 박재갑, 박찬일, 김노경. 종양학. 서울, 일조각, p227, 2009. |
6 | 이귀녕, 권오헌. 임상병리파일. 서울, 의학문화사, p347, 1045-1049, 1060-1066, 1075-1081, 2003. |
7 | 烏山 一, 강호일 역. 면역학 일러스트 맵. 서울, 월드사이언스, p52, 2009. |
8 | Abbas, A.K., Lichtman, A.H., 김각균 역. 최신면역학입문 3판. 서울, 이퍼블릭, p34, 2009. |
9 | Hercend, T., Schmidt, R.E. Characteristics and uses of natural killer cells. Immunol Today. 9(10):291-293, 1988. DOI |
10 | Trinchieri, G. Biology of natural killer cells. Adv Immunol. 47:187-376, 1989. |
11 | Whiteside, T.L., Herberman, R.B. Role of human natural killer cells in health and disease. Clin Diagn Lab Immunol. 1(2):125-133, 1994. |
12 | 미생물 면역분과학회. 최신면역학. 서울, 라이프사이언스, p14-15, 2011. |
13 | Hata, K., Zhang, X.R., Iwatsuki, S., Van Thiel, D.H., Herberman, R.B., Whiteside, T.L. Isolation, phenotyping, and functional analysis of lymphocytes from human liver. Clin Immunol Immunopathol. 56(3):401-419, 1990. DOI |
14 | Melief, C.J., Kast, W.M. Lessons from T cell responses to virus induced tumours for cancer eradication in general. Cancer Surv. 13:81-99, 1992. |
15 | Standish, L.J., Sweet, E.S., Novack, J., Wenner, C.A., Bridge, C., Nelson, A., Martzen, M., Torkelson, C. Breast cancer and the immune system. J Soc Integr Oncol. 6(4):158-168, 2008. |
16 | Cunningham-Rundles, S., Filippa, D.A., Braun, D.W. Jr., Antonelli, P., Ashikari, H. Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. J Natl Cancer Inst. 67(3):585-590, 1981. |
17 | Garner, W.L., Minton, J.P., James, A.G., Hoffmann, C.C. Human breast cancer and impaired NK cell function. J Surg Oncol. 24(1):64-66, 1983. DOI |
18 | Levy, S., Herberman, R., Lippman, M., d'Angelo, T. Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. J Clin Oncol. 5(3):348-353, 1987. DOI |
19 | Fulton, A., Heppner, G., Roi, L., Howard, L., Russo, J., Brennan, M. Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer. Breast Cancer Res Treat. 4(2):109-116, 1984. DOI |
20 | Hacene, K., Desplaces, A., Brunet, M., Lidereau, R., Bourguignat, A., Oglobine, J. Competitive prognostic value of clinicopathologic and bioimmunologic factors in primary breast cancer. Cancer. 57(2):245-250, 1986. DOI |
21 | Mohanty, I., Nayak, M., Nanda, B.K. Cell mediated immune status in carcinoma breast. Indian J Pathol Microbiol. 34(1):1-6, 1991. |
22 | Tsavaris, N., Kosmas, C., Vadiaka, M., Kanelopoulos, P., Boulamatsis, D. Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer. 87(1):21-27, 2002. DOI |
23 | Hersey, P., Hobbs, A., Edwards, A., McCarthy, W.H., McGovern, V.J. Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients. Cancer Res. 42(1):363-368, 1982. |
24 | Saijo, N., Shimizu, E., Shibuya, M., Irimajiri, N., Takizawa, T., Eguchi, K., Shinkai, T., Tominaga, K., Shimabukuro, Z., Taniguchi, T., Hoshi, A. Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung. Br J Cancer. 46(2):180-189, 1982. DOI |
25 | Stewart, L.D., Ades, E.W. Prospective study of natural cytotoxicity in peripheral blood of patients with nonlymphoid solid malignancies. Clin Immunol Immunopathol. 31(1):78-86, 1984. DOI |
26 | Coca, S., Perez-Piqueras, J., Martinez, D., Colmenarejo, A., Saez, M.A., Vallejo, C., Martos, J.A., Moreno, M. The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 79(12):2320-2328, 1997. DOI |
27 | Schantz, S.P., Peters, L.J. Patterns of recurrence from head and neck cancer. An immunologic perspective. Am J Clin Oncol. 10(6):469-474, 1987. DOI |
28 | Oshita, H., Saji, S., Sugiyama, Y., Tanemura, H., Sakata, K., Tanaka, S., Ito, T. Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction. Nihon Geka Gakkai Zasshi. 86(10):1417-1425, 1985. |
29 | Takeuchi, H., Maehara, Y., Tokunaga, E., Koga, T., Kakeji, Y., Sugimachi, K. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis. Am J Gastroenterol. 96(2):574-578, 2001. DOI |
30 | Shunyakov, L., Ryan, C.K., Sahasrabudhe, D.M., Khorana, A.A. The influence of host response on colorectal cancer prognosis. Clin Colorectal Cancer. 4(1):38-45, 2004. DOI |
31 | Ma, C.P., Yu, D.S., Yeh, M.Y., Chang, S.Y., Han, S.H. Natural killer cell activity in patients with urologic cancer. Eur Urol. 13(6):397-400, 1987. DOI |
32 | Carballido, J., Alvarez-Mon, M., Solovera, O.J., Menendez-Ondina, L., Durantez, A. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol. 143(1):29-33, 1990. DOI |
33 | Soygur, T., Beduk, Y., Baltaci, S., Yaman, O., Tokgoz, G. The prognostic value of peripheral blood lymphocyte subsets in patients with bladder carcinoma treated using neoadjuvant M-VEC chemotherapy. BJU Int. 84(9):1069-1072, 1999. |
34 | Pross, H.F., Sterns, E., MacGillis, D.R. Natural killer cell activity in women at "high risk" for breast cancer, with and without benign breast syndrome. Int J Cancer. 34(3):303-308, 1984. DOI |
35 | Sachs, G., Rasoul-Rockenschaub, S., Aschauer, H., Spiess, K., Gober, I., Staffen, A., Zielinski, C. Lytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study. J Neuroimmunol. 59(1-2):83-89, 1995. DOI |
36 | Luo, J., Ling, Z., Mao, W. Circulating lymphocyte subsets in patients with lung cancer and their prognostic value. Zhongguo Fei Ai Za Zhi. 14(8):669-673, 2011. |
37 | Hamilton, G., Reiner, A., Teleky, B., Roth, E., Kolb, R., Spona, J., Jakesz, R. Natural killer cell activities of patients with breast cancer against different target cells. J Cancer Res Clin Oncol. 114(2):191-196, 1988. DOI |
38 | Hersey, P., Edwards, A., Milton, G.W., McCarthy, W.H. No evidence for an association between natural killer cell activity and prognosis in melanoma patients. Nat Immun Cell Growth Regul. 3(2):87-94, 1983-1984. |
39 | Lukomska, B., Olszewski, W.L., Engeset, A., Kolstad, P. The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer. Cancer. 51(3):465-469, 1983. DOI |
40 | 한국세포주은행 http://cancer.snu.ac.kr/sub/catalog.php?CatNo=27 |
41 | Whiteside, T.L., Herberman, R.B. The role of natural killer cells in human disease. Clin Immunol Immunopathol. 53(1):1-23, 1989. DOI |
42 | Atreya, I., Neurath, M.F. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies. Expert Rev Anticancer Ther. 8(4):561-572, 2008. DOI |
43 | Mitchell, D.A., Fecci, P.E., Sampson, J.H. Immunotherapy of malignant brain tumors. Immunol Rev. 222:70-100, 2008. DOI |
44 | Chu, C.S., Kim, S.H., June, C.H., Coukos, G. Immunotherapy opportunities in ovarian cancer. Expert Rev Anticancer Ther. 8(2):243-257, 2008. DOI |
45 | Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S., Aikou, T. Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer. 88(3):577-583, 2000. DOI |
46 | Takanami, I., Takeuchi, K., Giga, M. The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg. 121(6):1058-1063, 2001. DOI |
47 | Hsia, J.Y., Chen, J.T., Chen, C.Y., Hsu, C.P., Miaw, J., Huang, Y.S., Yang, C.Y. Prognostic significance of intratumoral natural killer cells in primary resected esophageal squamous cell carcinoma. Chang Gung Med J. 28(5):335-340, 2005. |
48 | Turkseven, M.R., Oygur, T. Evaluation of natural killer cell defense in oral squamous cell carcinoma. Oral Oncol. 46(5):34-37, 2010. DOI |